FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304892759> ?p ?o ?g. }

• W4304892759 endingPage "59" @default.
• W4304892759 startingPage "53" @default.
• W4304892759 abstract "Prostate cancer (PC) is one of the most frequently diagnosed cancers in males. MiR-153, as a member of the microRNA (miRNA) family, plays an important role in PC. This study aims to explore the expression and possible molecular mechanisms of the miR-153 action. Formalin-fixed paraffin-embedded (FFPE) tissues were collected from prostatectomy specimens of 29 metastatic and 32 initial stage PC patients. Expression levels of miR-153 were measured using real-time reverse transcription polymerase chain reaction (qRT-PCR). 2−ΔΔCT method was used for quantitative gene expression assessment. The candidate target genes for miR-153 were predicted by TargetScan. Mutations in target genes of miR-153 were identified using exome sequencing. Protein-protein interaction (PPI) networks, Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the potential molecular mechanisms of miR-153 in PC. MiR-153 was significantly up-regulated in PC tissues compared to non-cancerous tissues. The analysis of correlation between the expression level of miR-153 and clinicopathological factors revealed a statistically significant correlation with the stage of the tumor process according to tumor, node, metastasis (TNM) staging system (p = 0.0256). ROC curve analysis was used to evaluate the predictive ability of miR-153 for metastasis development and it revealed miR-153 as a potential prognostic marker (AUC = 0.85; 95%CI 0.75–0.95; sensitivity = 0.72, specificity = 0.86)). According to logistic regression model the high expression of miR-153 increased the risk of metastasis development (odds ratios = 3.14, 95% CI 1.62–8.49; p-value = 0.006). Whole exome sequencing revealed nonsynonymous somatic mutations in collagen type IV alpha 1 (COL4A1), collagen type IV alpha 3 (COL4A3), forkhead box protein O1 (FOXO1), 2-hydroxyacyl-CoA lyase 1 (HACL1), hypoxia-inducible factor 1-alpha (HIF-1A), and nidogen 2 (NID2) genes. Moreover, KEGG analysis revealed that the extracellular matrix–receptor (ECM-receptor) interaction pathway is mainly involved in PC. MiR-153 is up-regulated in PC tissues and may play an important role in aggressive PC by targeting potential target genes." @default.
• W4304892759 created "2022-10-13" @default.
• W4304892759 creator A5009024162 @default.
• W4304892759 creator A5034148675 @default.
• W4304892759 creator A5035122818 @default.
• W4304892759 creator A5040838582 @default.
• W4304892759 creator A5050102246 @default.
• W4304892759 creator A5056314864 @default.
• W4304892759 creator A5058282202 @default.
• W4304892759 creator A5069375106 @default.
• W4304892759 creator A5070464260 @default.
• W4304892759 date "2023-03-01" @default.
• W4304892759 modified "2023-09-24" @default.
• W4304892759 title "The potential of miR-153 as aggressive prostate cancer biomarker" @default.
• W4304892759 cites W1604992442 @default.
• W4304892759 cites W1647809223 @default.
• W4304892759 cites W1901661730 @default.
• W4304892759 cites W2001604240 @default.
• W4304892759 cites W2005574242 @default.
• W4304892759 cites W2036724487 @default.
• W4304892759 cites W2046591786 @default.
• W4304892759 cites W2068675451 @default.
• W4304892759 cites W209525079 @default.
• W4304892759 cites W2105924489 @default.
• W4304892759 cites W2124097392 @default.
• W4304892759 cites W2146560284 @default.
• W4304892759 cites W2159219840 @default.
• W4304892759 cites W2166353463 @default.
• W4304892759 cites W2166480856 @default.
• W4304892759 cites W2167531245 @default.
• W4304892759 cites W2171132469 @default.
• W4304892759 cites W2171447184 @default.
• W4304892759 cites W2262500441 @default.
• W4304892759 cites W2511949746 @default.
• W4304892759 cites W2523925493 @default.
• W4304892759 cites W2604337946 @default.
• W4304892759 cites W2766480949 @default.
• W4304892759 cites W2774207124 @default.
• W4304892759 cites W2794445638 @default.
• W4304892759 cites W2803132729 @default.
• W4304892759 cites W2860348492 @default.
• W4304892759 cites W2889512114 @default.
• W4304892759 cites W2896737957 @default.
• W4304892759 cites W2897476064 @default.
• W4304892759 cites W2900866810 @default.
• W4304892759 cites W2905370328 @default.
• W4304892759 cites W2929514527 @default.
• W4304892759 cites W2976284872 @default.
• W4304892759 cites W2983431355 @default.
• W4304892759 cites W2995713074 @default.
• W4304892759 cites W3000293493 @default.
• W4304892759 cites W3045818159 @default.
• W4304892759 cites W3147142721 @default.
• W4304892759 cites W3147205760 @default.
• W4304892759 cites W3155155434 @default.
• W4304892759 cites W4289710937 @default.
• W4304892759 cites W4296530021 @default.
• W4304892759 cites W91582749 @default.
• W4304892759 doi "https://doi.org/10.1016/j.ncrna.2022.10.002" @default.
• W4304892759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36329790" @default.
• W4304892759 hasPublicationYear "2023" @default.
• W4304892759 type Work @default.
• W4304892759 citedByCount "0" @default.
• W4304892759 crossrefType "journal-article" @default.
• W4304892759 hasAuthorship W4304892759A5009024162 @default.
• W4304892759 hasAuthorship W4304892759A5034148675 @default.
• W4304892759 hasAuthorship W4304892759A5035122818 @default.
• W4304892759 hasAuthorship W4304892759A5040838582 @default.
• W4304892759 hasAuthorship W4304892759A5050102246 @default.
• W4304892759 hasAuthorship W4304892759A5056314864 @default.
• W4304892759 hasAuthorship W4304892759A5058282202 @default.
• W4304892759 hasAuthorship W4304892759A5069375106 @default.
• W4304892759 hasAuthorship W4304892759A5070464260 @default.
• W4304892759 hasBestOaLocation W43048927591 @default.
• W4304892759 hasConcept C104317684 @default.
• W4304892759 hasConcept C121608353 @default.
• W4304892759 hasConcept C126322002 @default.
• W4304892759 hasConcept C143998085 @default.
• W4304892759 hasConcept C145059251 @default.
• W4304892759 hasConcept C146357865 @default.
• W4304892759 hasConcept C150194340 @default.
• W4304892759 hasConcept C151730666 @default.
• W4304892759 hasConcept C152724338 @default.
• W4304892759 hasConcept C2775905019 @default.
• W4304892759 hasConcept C2779013556 @default.
• W4304892759 hasConcept C2780192828 @default.
• W4304892759 hasConcept C2781197716 @default.
• W4304892759 hasConcept C2987395477 @default.
• W4304892759 hasConcept C48023723 @default.
• W4304892759 hasConcept C502942594 @default.
• W4304892759 hasConcept C54355233 @default.
• W4304892759 hasConcept C60644358 @default.
• W4304892759 hasConcept C71924100 @default.
• W4304892759 hasConcept C86803240 @default.
• W4304892759 hasConceptScore W4304892759C104317684 @default.
• W4304892759 hasConceptScore W4304892759C121608353 @default.
• W4304892759 hasConceptScore W4304892759C126322002 @default.
• W4304892759 hasConceptScore W4304892759C143998085 @default.

• next